Condition (MeSH)
Vaginal Fistula
ClinicalTrials.gov lists 25 trials for Vaginal Fistula or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 25 trials are tagged with Vaginal Fistula itself; the rest are tagged with a narrower condition beneath it.
When did Vaginal Fistula trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2023 | 3 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 2 |
| 2019 | 3 |
| 2018 | 1 |
| 2017 | 4 |
| 2016 | 2 |
| 2012 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Vaginal Fistula trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 1/2 | 3 |
| Phase 2 | 1 |
| Phase 4 | 1 |
| Not applicable | 11 |
| Observational | 7 |
How many Vaginal Fistula trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Completed | 15 |
| Suspended | 1 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Vaginal Fistula trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Cook Group Incorporated | 1 |
| Government Ayurved College and Hospital | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| MSC-AFP | 1 |
| Adipose-derived stem cells without expanded | 1 |
| Stem Cells,Mesenchymal | 1 |
| Expanded allogenic adipose-derived adult stem cells | 1 |
| Hyperbaric oxygen treatment | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Vaginal Fistula? (29)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Womens' experiences of living with obstetric fistula in Ghana-time for the establishment of a fistula centre of excellence. | Midwifery | 2020 | Yes |
| Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer. | Gynecologic oncology | 2020 | Yes |
| Trajectories of women's physical and psychosocial health following obstetric fistula repair in Uganda: a longitudinal study. | Tropical medicine & international health : TM & IH | 2019 | Yes |
| Development and preliminary validation of a post-fistula repair reintegration instrument among Ugandan women. | Reproductive health | 2017 | Yes |
| Fistula recurrence, pregnancy, and childbirth following successful closure of female genital fistula in Guinea: a longitudinal study. | The Lancet. Global health | 2017 | Yes |
Showing 5 of 29 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.